لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Marks DI; United Bristol Healthcare Trust, Bristol, UK., Kirkwood AA; CR UK and UCL Cancer Trial Centre, Cancer Institute, University College London, London, UK., Rowntree CJ; Cardiff and Vale University Health Board, Cardiff, UK., Aguiar M; University College London Cancer Institute, London, UK., Bailey KE; University College London Cancer Institute, London, UK., Beaton B; University College London Cancer Institute, London, UK., Cahalin P; Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, UK., Castleton AZ; The Christie NHS Foundation Trust, Manchester, UK., Clifton-Hadley L; CR UK and UCL Cancer Trial Centre, Cancer Institute, University College London, London, UK., Copland M; Paul O'Gorman Leukaemia Research Centre, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Goldstone AH; University College London Cancer Institute, London, UK., Kelly R; St James's University Hospital, Leeds, UK., Lawrie E; CR UK and UCL Cancer Trial Centre, Cancer Institute, University College London, London, UK., Lee S; University College London Cancer Institute, London, UK., McMillan AK; Centre for Clinical Haematology, Nottingham City Hospital, Nottingham, UK., McMullin MF; Haematology, Queen's University, Belfast, UK., Menne TF; Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Mitchell RJ; University College London Cancer Institute, London, UK., Moorman AV; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle, UK., Patel B; Barts Cancer Institute, The London School of Medicine, Queen Mary University of London, London, UK., Patrick P; CR UK and UCL Cancer Trial Centre, Cancer Institute, University College London, London, UK., Smith P; CR UK and UCL Cancer Trial Centre, Cancer Institute, University College London, London, UK., Taussig D; Haemato-Oncology Section, Royal Marsden Hospital, Sutton, UK., Yallop D; King's College Hospital NHS Foundation Trust, London, UK., Alapi KZ; University College London Cancer Institute, London, UK., Fielding AK; University College London Cancer Institute, London, UK. Electronic address: a.fielding@ucl.ac.uk.

المصدر: The Lancet. Haematology [Lancet Haematol] 2022 Apr; Vol. 9 (4), pp. e262-e275.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Induction Chemotherapy* , Precursor Cell Lymphoblastic Leukemia-Lymphoma*, Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Female ; Humans ; Male ; Middle Aged ; Precursor Cells, B-Lymphoid ; Rituximab/adverse effects ; State Medicine ; Young Adult

المؤلفون: Marks DI; Adult BMT Unit, Bristol Haematology and Oncology Unit, University Hospitals Bristol NHS Trust, Bristol, UK. Electronic address: david.marks@uhbw.nhs.uk., Clifton-Hadley L; Cancer Research UK and UCL Cancer Trial Centre, UCL Cancer Institute, University College London, London, UK., Copland M; Paul O'Gorman Leukaemia Research Centre, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Hussain J; Cancer Research UK and UCL Cancer Trial Centre, UCL Cancer Institute, University College London, London, UK., Menne TF; Department of Haematology, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., McMillan A; Centre for Clinical Haematology, Nottingham City Hospital, Nottingham, UK., Moorman AV; Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, UK., Morley N; Department of Haematology, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK., Okasha D; Cancer Institute, University College London, London, UK., Patel B; Barts Cancer Institute, The London School of Medicine, Queen Mary University of London, London, UK., Patrick P; Cancer Research UK and UCL Cancer Trial Centre, UCL Cancer Institute, University College London, London, UK., Potter MN; Department of Haematology, Royal Marsden Hospital, Sutton, UK., Rowntree CJ; Cardiff and Vale University Health Board, Cardiff, UK., Kirkwood AA; Cancer Research UK and UCL Cancer Trial Centre, UCL Cancer Institute, University College London, London, UK., Fielding AK; Cancer Institute, University College London, London, UK.

المصدر: The Lancet. Haematology [Lancet Haematol] 2022 Apr; Vol. 9 (4), pp. e276-e288.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Epstein-Barr Virus Infections* , Hematopoietic Stem Cell Transplantation*/adverse effects , Hematopoietic Stem Cell Transplantation*/methods , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy, Adult ; Aged ; Female ; Herpesvirus 4, Human ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; Prospective Studies ; T-Lymphocytes ; Unrelated Donors

المؤلفون: Mitchell RJ; Haematology and., Kirkwood AA; Cancer Research UK (CRUK) and University College London (UCL) Cancer Trials Centre, UCL Cancer Institute, UCL, London, United Kingdom and., Barretta E; Northern Institute for Cancer Research, University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom and., Clifton-Hadley L; Cancer Research UK (CRUK) and University College London (UCL) Cancer Trials Centre, UCL Cancer Institute, UCL, London, United Kingdom and., Lawrie E; Cancer Research UK (CRUK) and University College London (UCL) Cancer Trials Centre, UCL Cancer Institute, UCL, London, United Kingdom and., Lee S; Haematology and., Leongamornlert D; Wellcome Sanger Centre, Hinxton, United Kingdom and., Marks DI; United Bristol Healthcare Trust, Bristol, United Kingdom and., McMillan AK; Centre for Clinical Haematology, Nottingham City Hospital, Nottingham, United Kingdom and., Menne TF; Newcastle Upon Tyne Hospitals National Health Service (NHS) Foundation Trust, Newcastle upon Tyne, United Kingdom and., Papaemmanuil E; Memorial Sloan Kettering Cancer Center, New York, NY and., Patel B; Barts Cancer Institute, The London School of Medicine, Queen Mary University of London, London, United Kingdom; and., Patrick P; Cancer Research UK (CRUK) and University College London (UCL) Cancer Trials Centre, UCL Cancer Institute, UCL, London, United Kingdom and., Rowntree CJ; Cardiff and Vale University Health Board (UHB), Wales, United Kingdom., Zareian N; Haematology and., Alapi KZ; Haematology and., Moorman AV; Northern Institute for Cancer Research, University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom and., Fielding AK; Haematology and.

المصدر: Blood advances [Blood Adv] 2021 Sep 14; Vol. 5 (17), pp. 3322-3332.

نوع المنشور: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Burkitt Lymphoma* , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics, Adult ; Aged ; Fusion Proteins, bcr-abl/genetics ; Humans ; Ikaros Transcription Factor/genetics ; Middle Aged ; Polymerase Chain Reaction

المؤلفون: Moss JG; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK. Electronic address: jonathan.moss@glasgow.ac.uk., Wu O; Health Economics and Health Technology Assessment, Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK., Bodenham AR; Intensive Care, Leeds General Infirmary, Leeds, UK., Agarwal R; Department of Oncology, Northampton General Hospital, Northampton, UK., Menne TF; Department of Haematology, The Freeman Hospital, Newcastle upon Tyne, UK., Jones BL; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK., Heggie R; Health Economics and Health Technology Assessment, Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK., Hill S; Procedure Unit, The Christie NHS Foundation Trust, Withington, UK., Dixon-Hughes J; Cancer Research UK Glasgow Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Soulis E; Cancer Research UK Glasgow Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Germeni E; Health Economics and Health Technology Assessment, Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK., Dillon S; Cancer Research UK Glasgow Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., McCartney E; Cancer Research UK Glasgow Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.

مؤلفون مشاركون: CAVA trial group

المصدر: Lancet (London, England) [Lancet] 2021 Jul 31; Vol. 398 (10298), pp. 403-415. Date of Electronic Publication: 2021 Jul 21.

نوع المنشور: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

مواضيع طبية MeSH: Catheterization, Peripheral*/adverse effects , Catheters, Indwelling*/adverse effects , Catheters, Indwelling*/economics , Central Venous Catheters*/adverse effects , Central Venous Catheters*/economics , Vascular Access Devices*/economics, Antineoplastic Agents/*administration & dosage , Neoplasms/*drug therapy, Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/therapeutic use ; Catheter-Related Infections/etiology ; Cost-Benefit Analysis ; Female ; Humans ; Male ; Middle Aged ; Young Adult

المؤلفون: Shah N; Norfolk & Norwich University Hospitals NHS Foundation Trust, Norwich, UK., Eyre TA; Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Tucker D; Royal Cornwall Hospitals NHS Trust, Truro, UK., Kassam S; King's College Hospital NHS Foundation Trust, London, UK., Parmar J; Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK., Featherstone C; Greater Glasgow and Clyde NHS, Glasgow, UK., Andrews P; Epsom and St Helier University Hospitals NHS Trust, Surrey, UK., Asgari E; Guy's and St Thomas' NHS Foundation Trust, London, UK., Chaganti S; Queen Elizabeth Hospital, Birmingham, UK., Menne TF; The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK., Fox CP; Nottingham University Hospitals NHS Trust, Nottingham, UK., Pettit S; Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK., Suddle A; King's College Hospital NHS Foundation Trust, London, UK., Bowles KM; Norfolk & Norwich University Hospitals NHS Foundation Trust, Norwich, UK.; Norwich Medical School, University of East Anglia, Norwich, UK.

مؤلفون مشاركون: Haemato-Oncology Task Force of the British Society for Haematology and the British Transplantation Society

المصدر: British journal of haematology [Br J Haematol] 2021 May; Vol. 193 (4), pp. 727-740. Date of Electronic Publication: 2021 Apr 20.

نوع المنشور: Journal Article; Practice Guideline

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Hematology* , Lymphoproliferative Disorders*/diagnosis , Lymphoproliferative Disorders*/etiology , Lymphoproliferative Disorders*/therapy , Organ Transplantation* , Societies, Medical*, Adult ; Humans ; United Kingdom

المؤلفون: Patel B; Barts Cancer Institute, The London School of Medicine, Queen Mary University of London, London, UK., Kirkwood AA; CR UK and UCL Cancer Trials Centre, London, UK., Dey A; Cancer Institute, University College London, London, UK., Marks DI; Centre for Clinical Haematology, Nottingham City Hospital, Nottingham, UK., McMillan AK; United Bristol Healthcare Trust, Bristol, UK., Menne TF; Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK., Micklewright L; CR UK and UCL Cancer Trials Centre, London, UK., Patrick P; CR UK and UCL Cancer Trials Centre, London, UK., Purnell S; CR UK and UCL Cancer Trials Centre, London, UK., Rowntree CJ; Cardiff and Vale UHB, London, UK., Smith P; CR UK and UCL Cancer Trials Centre, London, UK., Fielding AK; Cancer Institute, University College London, London, UK.

المصدر: Leukemia [Leukemia] 2017 Jan; Vol. 31 (1), pp. 58-64. Date of Electronic Publication: 2016 Aug 02.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Asparaginase/*toxicity , Polyethylene Glycols/*toxicity , Precursor Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy, Adult ; Age Factors ; Aged ; Antineoplastic Agents/administration & dosage ; Antineoplastic Agents/toxicity ; Asparaginase/administration & dosage ; Asparaginase/pharmacokinetics ; Chemical and Drug Induced Liver Injury/mortality ; Humans ; Induction Chemotherapy/methods ; Middle Aged ; Philadelphia Chromosome ; Polyethylene Glycols/administration & dosage ; Polyethylene Glycols/pharmacokinetics ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/complications ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality ; Sepsis/chemically induced ; Sepsis/mortality

المؤلفون: Maclean GA; Division of Hematology/Oncology, Boston Children's Hospital and Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA., Menne TF, Guo G, Sanchez DJ, Park IH, Daley GQ, Orkin SH

المصدر: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2012 Oct 23; Vol. 109 (43), pp. 17567-72. Date of Electronic Publication: 2012 Oct 08.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE

مواضيع طبية MeSH: Cell Differentiation* , Down Syndrome* , Hematopoiesis*, Pluripotent Stem Cells/*cytology, Gene Expression Profiling ; Humans ; Karyotyping ; Polymerase Chain Reaction

المؤلفون: Menne J; Medical School Hannover, Hannover, Germany., Nitschke M, Stingele R, Abu-Tair M, Beneke J, Bramstedt J, Bremer JP, Brunkhorst R, Busch V, Dengler R, Deuschl G, Fellermann K, Fickenscher H, Gerigk C, Goettsche A, Greeve J, Hafer C, Hagenmüller F, Haller H, Herget-Rosenthal S, Hertenstein B, Hofmann C, Lang M, Kielstein JT, Klostermeier UC, Knobloch J, Kuehbacher M, Kunzendorf U, Lehnert H, Manns MP, Menne TF, Meyer TN, Michael C, Münte T, Neumann-Grutzeck C, Nuernberger J, Pavenstaedt H, Ramazan L, Renders L, Repenthin J, Ries W, Rohr A, Rump LC, Samuelsson O, Sayk F, Schmidt BM, Schnatter S, Schöcklmann H, Schreiber S, von Seydewitz CU, Steinhoff J, Stracke S, Suerbaum S, van de Loo A, Vischedyk M, Weissenborn K, Wellhöner P, Wiesner M, Zeissig S, Büning J, Schiffer M, Kuehbacher T

مؤلفون مشاركون: EHEC-HUS consortium

المصدر: BMJ (Clinical research ed.) [BMJ] 2012 Jul 19; Vol. 345, pp. e4565. Date of Electronic Publication: 2012 Jul 19.

نوع المنشور: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Validation Study

بيانات الدورية: Publisher: British Medical Association Country of Publication: England NLM ID: 8900488 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-1833 (Electronic) Linking ISSN: 09598138 NLM ISO Abbreviation: BMJ Subsets: MEDLINE

مواضيع طبية MeSH: Disease Outbreaks* , Enterohemorrhagic Escherichia coli*, Anti-Bacterial Agents/*therapeutic use , Antibodies, Monoclonal, Humanized/*therapeutic use , Escherichia coli Infections/*therapy , Hemolytic-Uremic Syndrome/*therapy , Immunologic Factors/*therapeutic use, Adolescent ; Adult ; Aged ; Aged, 80 and over ; Animals ; Anti-Bacterial Agents/administration & dosage ; Antibodies, Monoclonal, Humanized/administration & dosage ; Case-Control Studies ; Child ; Combined Modality Therapy ; Diarrhea/microbiology ; Disease Progression ; Drug Therapy, Combination ; Escherichia coli Infections/blood ; Escherichia coli Infections/epidemiology ; Escherichia coli Infections/microbiology ; Female ; Germany/epidemiology ; Glucocorticoids/administration & dosage ; Glucocorticoids/therapeutic use ; Hemolytic-Uremic Syndrome/blood ; Hemolytic-Uremic Syndrome/epidemiology ; Hemolytic-Uremic Syndrome/microbiology ; Humans ; Immunologic Factors/administration & dosage ; Infant ; L-Lactate Dehydrogenase/blood ; Male ; Mice ; Middle Aged ; Multivariate Analysis ; Plasmapheresis/methods ; Platelet Count ; Renal Dialysis/statistics & numerical data ; Respiration, Artificial/statistics & numerical data ; Retrospective Studies ; Treatment Outcome ; Young Adult

المؤلفون: Finch AJ; Medical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom. ajw@mrc-lmb.cam.ac.uk, Hilcenko C, Basse N, Drynan LF, Goyenechea B, Menne TF, González Fernández A, Simpson P, D'Santos CS, Arends MJ, Donadieu J, Bellanné-Chantelot C, Costanzo M, Boone C, McKenzie AN, Freund SM, Warren AJ

المصدر: Genes & development [Genes Dev] 2011 May 01; Vol. 25 (9), pp. 917-29.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Cold Spring Harbor Laboratory Press Country of Publication: United States NLM ID: 8711660 Publication Model: Print Cited Medium: Internet ISSN: 1549-5477 (Electronic) Linking ISSN: 08909369 NLM ISO Abbreviation: Genes Dev Subsets: MEDLINE

مواضيع طبية MeSH: Eukaryotic Initiation Factors/*metabolism , Guanosine Triphosphate/*metabolism , Ribosomes/*pathology, Animals ; Bone Marrow Diseases/genetics ; Bone Marrow Diseases/physiopathology ; Catalysis ; Cells, Cultured ; Disease Models, Animal ; Eukaryotic Initiation Factors/genetics ; Exocrine Pancreatic Insufficiency/genetics ; Exocrine Pancreatic Insufficiency/physiopathology ; Humans ; Hydrolysis ; Lipomatosis ; Liver/pathology ; Mice ; Mice, Inbred C57BL ; Models, Molecular ; Mutation ; Peptide Initiation Factors/genetics ; Peptide Initiation Factors/metabolism ; Phosphorylation ; Protein Binding ; Protein Structure, Tertiary ; Proteins/chemistry ; Proteins/genetics ; Proteins/metabolism ; Ribosome Subunits, Large, Eukaryotic ; Shwachman-Diamond Syndrome

SCR Disease Name: Shwachman syndrome